530 related articles for article (PubMed ID: 21705072)
1. Type 2 diabetes across generations: from pathophysiology to prevention and management.
Nolan CJ; Damm P; Prentki M
Lancet; 2011 Jul; 378(9786):169-81. PubMed ID: 21705072
[TBL] [Abstract][Full Text] [Related]
2. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
3. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.
Defronzo RA
Diabetes; 2009 Apr; 58(4):773-95. PubMed ID: 19336687
[No Abstract] [Full Text] [Related]
4. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.
DeFronzo RA
Am J Med; 2010 Mar; 123(3 Suppl):S38-48. PubMed ID: 20206731
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology of insulin resistance].
Häring H
Herz; 1995 Feb; 20(1):5-15. PubMed ID: 7713477
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of prediabetes.
Bhansali A; Dutta P
J Indian Med Assoc; 2005 Nov; 103(11):594-5, 599. PubMed ID: 16570762
[TBL] [Abstract][Full Text] [Related]
7. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
Karaca M; Magnan C; Kargar C
Diabetes Metab; 2009 Apr; 35(2):77-84. PubMed ID: 19251449
[TBL] [Abstract][Full Text] [Related]
8. Maternal diabetes, programming of beta-cell disorders and intergenerational risk of type 2 diabetes.
Chavey A; Ah Kioon MD; Bailbé D; Movassat J; Portha B
Diabetes Metab; 2014 Nov; 40(5):323-30. PubMed ID: 24948417
[TBL] [Abstract][Full Text] [Related]
9. Impact of fetal and neonatal environment on beta cell function and development of diabetes.
Nielsen JH; Haase TN; Jaksch C; Nalla A; Søstrup B; Nalla AA; Larsen L; Rasmussen M; Dalgaard LT; Gaarn LW; Thams P; Kofod H; Billestrup N
Acta Obstet Gynecol Scand; 2014 Nov; 93(11):1109-22. PubMed ID: 25225114
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus.
Tataranni PA
Eur Rev Med Pharmacol Sci; 2002; 6(2-3):27-32. PubMed ID: 12708607
[No Abstract] [Full Text] [Related]
11. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.
van Genugten RE; van Raalte DH; Diamant M
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S26-34. PubMed ID: 20115929
[TBL] [Abstract][Full Text] [Related]
12. Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes.
Vaag A; Brøns C; Gillberg L; Hansen NS; Hjort L; Arora GP; Thomas N; Broholm C; Ribel-Madsen R; Grunnet LG
Acta Obstet Gynecol Scand; 2014 Nov; 93(11):1099-108. PubMed ID: 25179736
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of prediabetes.
Ferrannini E; Gastaldelli A; Iozzo P
Med Clin North Am; 2011 Mar; 95(2):327-39, vii-viii. PubMed ID: 21281836
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
Virally M; Blicklé JF; Girard J; Halimi S; Simon D; Guillausseau PJ
Diabetes Metab; 2007 Sep; 33(4):231-44. PubMed ID: 17703979
[TBL] [Abstract][Full Text] [Related]
16. Metabolic aspects of insulin resistance in individuals born small for gestational age.
Vaag A; Jensen CB; Poulsen P; Brøns C; Pilgaard K; Grunnet L; Vielwerth S; Alibegovic A
Horm Res; 2006; 65 Suppl 3():137-43. PubMed ID: 16612127
[TBL] [Abstract][Full Text] [Related]
17. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.
Geloneze B; Geloneze SR; Chaim E; Hirsch FF; Felici AC; Lambert G; Tambascia MA; Pareja JC
Ann Surg; 2012 Jul; 256(1):72-8. PubMed ID: 22664560
[TBL] [Abstract][Full Text] [Related]
18. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue.
Lauro D; Kido Y; Castle AL; Zarnowski MJ; Hayashi H; Ebina Y; Accili D
Nat Genet; 1998 Nov; 20(3):294-8. PubMed ID: 9806552
[TBL] [Abstract][Full Text] [Related]
20. Intergenerational transmission of insulin resistance and type 2 diabetes.
Poston L
Prog Biophys Mol Biol; 2011 Jul; 106(1):315-22. PubMed ID: 21167194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
